Abstract
Angiotensin II (Ang II), the dominant effector of the renin-angiotensin system, elicits numerous inflammatory-proliferative responses, thereby being involved in angiogenesis. T cells play an important role in angiogenesis as well by delivering vascular endothelial growth factor (VEGF) to inflammatory sites. Since we have previously shown that pigment-epithelium-derived factor (PEDF) blocks the Ang II signaling in endothelial cells, we studied here whether PEDF could inhibit the Ang-II-induced VEGF expression in MOLT-3 T and examined the potential mechanism of PEDF inhibitory effects. Ang II significantly up-regulated VEGF mRNA levels in MOLT-3 T cells, which was inhibited by PEDF or olmesartan, an Ang II type 1 receptor blocker. PEDF blocked the Ang-II-induced reactive oxygen species (ROS) generation in MOLT-3 T cells. Furthermore, H(2)O(2) was found to up-regulate VEGF mRNA levels in MOLT-3 T cells in a dose-dependent manner. These results demonstrate that PEDF could inhibit the Ang-II-induced VEGF expression in MOLT-3 T cells via suppression of ROS generation. Blockade by PEDF of VEGF expression in T cells may become a novel therapeutic target for pathological angiogenesis.
References
Sep 1, 1991·Experimental Eye Research·J Tombran-TinkL V Johnson
Jun 1, 1994·Circulation Research·K K GriendlingR W Alexander
Jul 10, 1999·Science·D W DawsonN P Bouck
May 26, 2001·Diabetes·S I YamagishiM Brownlee
Mar 26, 2002·The Journal of Biological Chemistry·Sho-ichi YamagishiZenji Makita
Aug 30, 2002·Biochemical and Biophysical Research Communications·Sho-ichi YamagishiZenji Makita
May 10, 2003·The Biochemical Journal·Steen V PetersenJan J Enghild
Jul 4, 2003·The Journal of Clinical Investigation·Kimiyasu EgamiTsutomu Imaizumi
Mar 23, 2004·Current Drug Targets. Inflammation and Allergy·Claudia MonacoEwa Paleolog
Jun 24, 2004·British Journal of Pharmacology·Shu-Meng ChengJenn-Haung Lai
Dec 8, 2004·Current Cancer Drug Targets·Hitoshi YoshijiHiroshi Fukui
Apr 23, 2005·Cell and Tissue Research·Sho-Ichi YamagishiTsutomu Imaizumi
Citations
Sep 3, 2009·The Journal of Biological Chemistry·Zsolt AblonczyKumar Sambamurti
Mar 29, 2007·The British Journal of Ophthalmology·Yumiko YoshidaRyoji Yamakawa
Jul 24, 2010·Journal of Ophthalmology·Masayoshi TakeuchiSho-Ichi Yamagishi
Aug 22, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Susumu OgawaSadayoshi Ito
Jun 15, 2014·The Journal of Endocrinology·Mina ElahyCrispin R Dass
Jun 14, 2008·Expert Opinion on Investigational Drugs·Sho-Ichi YamagishiSeiya Okuda
May 4, 2010·Chest·Kathrin RychliJohann Wojta
Feb 5, 2013·Biochemical and Biophysical Research Communications·Ritsuko SekiTakashi Okamura
Dec 23, 2015·Archives of Gynecology and Obstetrics·Nur ŞahinFatma Eskicioğlu
Oct 6, 2012·The Prostate·Thomas NeliusStéphanie Filleur
Aug 25, 2015·Clinical Epigenetics·Cécile ChouxPatricia Fauque
Oct 29, 2013·Biochemical and Biophysical Research Communications·Takanori MatsuiSho-ichi Yamagishi
Mar 13, 2010·Dermato-endocrinology·Cheng-Feng ZhangZhi-Zhong Zheng
Dec 18, 2013·Biochemical and Biophysical Research Communications·Takanori MatsuiSho-ichi Yamagishi
Mar 21, 2019·Current Pharmaceutical Design·Sho-Ichi YamagishiMinoru Yagi
Mar 22, 2016·Oncology Letters·Jialin QianBaohui Han
Nov 11, 2018·Life Sciences·Xing-Hui LiWei-Bin Cai